Financial report interval: 2025.12.31 - 2026.03.31
Preview: ANI Pharma(ANIP) predict that the Revenue is 237.46 M (+20.46%), Beat estimate;the EBIT is 38.89 M (+48.46%), Beat estimate;the EPS is 1.28 (+85.51%), Beat estimate.